SCHEMBL4972196

SCHEMBL4972196

COC(CNc1nc(Cl)nc(N2CCOCC2)c1F)c1ccc(F)cn1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 13/20 0.45
JAK3 P52333 11/20 0.45
NTRK1 P04629 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KCNH2 Q12809 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MTOR P42345 1/20 0.35
LRRK2 Q5S007 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4969772 0.88 JAK2 (0.48) JAK2JAK3SMN1; SMN2KDM4EALDH1A1
SCHEMBL4975407 0.84 JAK2 (0.46) JAK2JAK3SMN1; SMN2KDM4EALDH1A1
SCHEMBL4972050 0.83 JAK2 (0.46) JAK2JAK3NTRK1SMN1; SMN2KCNH2
SCHEMBL4972182 0.82 JAK2 (0.48) JAK2JAK3NTRK1SMN1; SMN2KCNH2
SCHEMBL14675794 0.81 JAK2 (0.64) JAK2JAK3NTRK1KCNH2
SCHEMBL4972207 0.81 JAK2 (0.64) JAK2JAK3NTRK1KCNH2
SCHEMBL4972038 0.80 JAK2 (0.49) JAK2JAK3NTRK1SMN1; SMN2KCNH2
SCHEMBL4972548 0.79 JAK2 (0.46) JAK2JAK3NTRK1SMN1; SMN2KCNH2
SCHEMBL4972280 0.78 JAK2 (0.60) JAK2JAK3NTRK1KCNH2
SCHEMBL4972215 0.77 JAK2 (0.39) JAK2JAK3NTRK1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed